Non-Narcotic Analgesics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Non Steroid Antiinflammatory, Drug Others); Application (Hospital, Medical Center, Others)
Report Code: TIPRE00011115 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Non-narcotic analgesics are medications that are used to control pain and inflammation. Non-narcotic is a drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. Some types of these medications can be given during surgery to reduce post-surgical pain and lessen the need for narcotics.
MARKET DYNAMICS
The non-narcotic analgesics market is expected to grow due to increasing number of diseases. Moreover, increase in research and development activities is propelling the market growth in the forecast period.
MARKET SCOPE
The "Non-Narcotic Analgesics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-narcotic analgesics market with detailed market segmentation by of product, and application. The non-narcotic analgesics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-narcotic analgesics market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The non-narcotic analgesics market is segmented on the basis of type and application. Based on type, the market is segmented as non-steroid antiinflammatory drug and others. On the basis of application, the market is categorized as hospital, medical center and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-narcotic analgesics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-narcotic analgesics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting non-narcotic analgesics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-narcotic analgesics market in these regions.
The report covers key developments in the non-narcotic analgesics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-narcotic analgesics market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-narcotic analgesics in the global market. Below mentioned is the list of few companies engaged in the non-narcotic analgesics market.
The report also includes the profiles of key players in non-narcotic analgesics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Non-narcotic analgesics are medications that are used to control pain and inflammation. Non-narcotic is a drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. Some types of these medications can be given during surgery to reduce post-surgical pain and lessen the need for narcotics.
MARKET DYNAMICS
The non-narcotic analgesics market is expected to grow due to increasing number of diseases. Moreover, increase in research and development activities is propelling the market growth in the forecast period.
MARKET SCOPE
The "Non-Narcotic Analgesics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of non-narcotic analgesics market with detailed market segmentation by of product, and application. The non-narcotic analgesics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in non-narcotic analgesics market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The non-narcotic analgesics market is segmented on the basis of type and application. Based on type, the market is segmented as non-steroid antiinflammatory drug and others. On the basis of application, the market is categorized as hospital, medical center and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the non-narcotic analgesics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-narcotic analgesics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting non-narcotic analgesics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-narcotic analgesics market in these regions.
The report covers key developments in the non-narcotic analgesics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from non-narcotic analgesics market are anticipated to have lucrative growth opportunities in the future with the rising demand for non-narcotic analgesics in the global market. Below mentioned is the list of few companies engaged in the non-narcotic analgesics market.
The report also includes the profiles of key players in non-narcotic analgesics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Akron, Inc.
- Allergan plc
- BioDelivery Sciences International, Inc.
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Novartis AG
- Pfizer
- Reckitt Benckiser
- Sanofi S.A.
- Teva Pharmaceuticals
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non Narcotic Analgesics Market - By Type
1.3.2 Non Narcotic Analgesics Market - By Application
1.3.3 Non Narcotic Analgesics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON NARCOTIC ANALGESICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON NARCOTIC ANALGESICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON NARCOTIC ANALGESICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NON NARCOTIC ANALGESICS - GLOBAL MARKET OVERVIEW
6.2. NON NARCOTIC ANALGESICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON NARCOTIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON STEROID ANTIINFLAMMATORY
7.3.1. Overview
7.3.2. Non Steroid Antiinflammatory Market Forecast and Analysis
7.4. DRUG OTHERS
7.4.1. Overview
7.4.2. Drug Others Market Forecast and Analysis
8. NON NARCOTIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. MEDICAL CENTER
8.4.1. Overview
8.4.2. Medical Center Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. NON NARCOTIC ANALGESICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non Narcotic Analgesics Market Overview
9.1.2 North America Non Narcotic Analgesics Market Forecasts and Analysis
9.1.3 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.1.4 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.1.5 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Non Narcotic Analgesics Market
9.1.5.1.1 United States Non Narcotic Analgesics Market by Type
9.1.5.1.2 United States Non Narcotic Analgesics Market by Application
9.1.5.2 Canada Non Narcotic Analgesics Market
9.1.5.2.1 Canada Non Narcotic Analgesics Market by Type
9.1.5.2.2 Canada Non Narcotic Analgesics Market by Application
9.1.5.3 Mexico Non Narcotic Analgesics Market
9.1.5.3.1 Mexico Non Narcotic Analgesics Market by Type
9.1.5.3.2 Mexico Non Narcotic Analgesics Market by Application
9.2. EUROPE
9.2.1 Europe Non Narcotic Analgesics Market Overview
9.2.2 Europe Non Narcotic Analgesics Market Forecasts and Analysis
9.2.3 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.2.4 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.2.5 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non Narcotic Analgesics Market
9.2.5.1.1 Germany Non Narcotic Analgesics Market by Type
9.2.5.1.2 Germany Non Narcotic Analgesics Market by Application
9.2.5.2 France Non Narcotic Analgesics Market
9.2.5.2.1 France Non Narcotic Analgesics Market by Type
9.2.5.2.2 France Non Narcotic Analgesics Market by Application
9.2.5.3 Italy Non Narcotic Analgesics Market
9.2.5.3.1 Italy Non Narcotic Analgesics Market by Type
9.2.5.3.2 Italy Non Narcotic Analgesics Market by Application
9.2.5.4 Spain Non Narcotic Analgesics Market
9.2.5.4.1 Spain Non Narcotic Analgesics Market by Type
9.2.5.4.2 Spain Non Narcotic Analgesics Market by Application
9.2.5.5 United Kingdom Non Narcotic Analgesics Market
9.2.5.5.1 United Kingdom Non Narcotic Analgesics Market by Type
9.2.5.5.2 United Kingdom Non Narcotic Analgesics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non Narcotic Analgesics Market Overview
9.3.2 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis
9.3.3 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non Narcotic Analgesics Market
9.3.5.1.1 Australia Non Narcotic Analgesics Market by Type
9.3.5.1.2 Australia Non Narcotic Analgesics Market by Application
9.3.5.2 China Non Narcotic Analgesics Market
9.3.5.2.1 China Non Narcotic Analgesics Market by Type
9.3.5.2.2 China Non Narcotic Analgesics Market by Application
9.3.5.3 India Non Narcotic Analgesics Market
9.3.5.3.1 India Non Narcotic Analgesics Market by Type
9.3.5.3.2 India Non Narcotic Analgesics Market by Application
9.3.5.4 Japan Non Narcotic Analgesics Market
9.3.5.4.1 Japan Non Narcotic Analgesics Market by Type
9.3.5.4.2 Japan Non Narcotic Analgesics Market by Application
9.3.5.5 South Korea Non Narcotic Analgesics Market
9.3.5.5.1 South Korea Non Narcotic Analgesics Market by Type
9.3.5.5.2 South Korea Non Narcotic Analgesics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non Narcotic Analgesics Market Overview
9.4.2 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis
9.4.3 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non Narcotic Analgesics Market
9.4.5.1.1 South Africa Non Narcotic Analgesics Market by Type
9.4.5.1.2 South Africa Non Narcotic Analgesics Market by Application
9.4.5.2 Saudi Arabia Non Narcotic Analgesics Market
9.4.5.2.1 Saudi Arabia Non Narcotic Analgesics Market by Type
9.4.5.2.2 Saudi Arabia Non Narcotic Analgesics Market by Application
9.4.5.3 U.A.E Non Narcotic Analgesics Market
9.4.5.3.1 U.A.E Non Narcotic Analgesics Market by Type
9.4.5.3.2 U.A.E Non Narcotic Analgesics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non Narcotic Analgesics Market Overview
9.5.2 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis
9.5.3 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non Narcotic Analgesics Market
9.5.5.1.1 Brazil Non Narcotic Analgesics Market by Type
9.5.5.1.2 Brazil Non Narcotic Analgesics Market by Application
9.5.5.2 Argentina Non Narcotic Analgesics Market
9.5.5.2.1 Argentina Non Narcotic Analgesics Market by Type
9.5.5.2.2 Argentina Non Narcotic Analgesics Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NON NARCOTIC ANALGESICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NON NARCOTIC ANALGESICS MARKET, KEY COMPANY PROFILES
12.1. AKRON, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIODELIVERY SCIENCES INTERNATIONAL, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ENDO PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RECKITT BENCKISER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI S.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Non Narcotic Analgesics Market - By Type
1.3.2 Non Narcotic Analgesics Market - By Application
1.3.3 Non Narcotic Analgesics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NON NARCOTIC ANALGESICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NON NARCOTIC ANALGESICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NON NARCOTIC ANALGESICS MARKET - GLOBAL MARKET ANALYSIS
6.1. NON NARCOTIC ANALGESICS - GLOBAL MARKET OVERVIEW
6.2. NON NARCOTIC ANALGESICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. NON NARCOTIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NON STEROID ANTIINFLAMMATORY
7.3.1. Overview
7.3.2. Non Steroid Antiinflammatory Market Forecast and Analysis
7.4. DRUG OTHERS
7.4.1. Overview
7.4.2. Drug Others Market Forecast and Analysis
8. NON NARCOTIC ANALGESICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. MEDICAL CENTER
8.4.1. Overview
8.4.2. Medical Center Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. NON NARCOTIC ANALGESICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Non Narcotic Analgesics Market Overview
9.1.2 North America Non Narcotic Analgesics Market Forecasts and Analysis
9.1.3 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.1.4 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.1.5 North America Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Non Narcotic Analgesics Market
9.1.5.1.1 United States Non Narcotic Analgesics Market by Type
9.1.5.1.2 United States Non Narcotic Analgesics Market by Application
9.1.5.2 Canada Non Narcotic Analgesics Market
9.1.5.2.1 Canada Non Narcotic Analgesics Market by Type
9.1.5.2.2 Canada Non Narcotic Analgesics Market by Application
9.1.5.3 Mexico Non Narcotic Analgesics Market
9.1.5.3.1 Mexico Non Narcotic Analgesics Market by Type
9.1.5.3.2 Mexico Non Narcotic Analgesics Market by Application
9.2. EUROPE
9.2.1 Europe Non Narcotic Analgesics Market Overview
9.2.2 Europe Non Narcotic Analgesics Market Forecasts and Analysis
9.2.3 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.2.4 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.2.5 Europe Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Non Narcotic Analgesics Market
9.2.5.1.1 Germany Non Narcotic Analgesics Market by Type
9.2.5.1.2 Germany Non Narcotic Analgesics Market by Application
9.2.5.2 France Non Narcotic Analgesics Market
9.2.5.2.1 France Non Narcotic Analgesics Market by Type
9.2.5.2.2 France Non Narcotic Analgesics Market by Application
9.2.5.3 Italy Non Narcotic Analgesics Market
9.2.5.3.1 Italy Non Narcotic Analgesics Market by Type
9.2.5.3.2 Italy Non Narcotic Analgesics Market by Application
9.2.5.4 Spain Non Narcotic Analgesics Market
9.2.5.4.1 Spain Non Narcotic Analgesics Market by Type
9.2.5.4.2 Spain Non Narcotic Analgesics Market by Application
9.2.5.5 United Kingdom Non Narcotic Analgesics Market
9.2.5.5.1 United Kingdom Non Narcotic Analgesics Market by Type
9.2.5.5.2 United Kingdom Non Narcotic Analgesics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Non Narcotic Analgesics Market Overview
9.3.2 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis
9.3.3 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Non Narcotic Analgesics Market
9.3.5.1.1 Australia Non Narcotic Analgesics Market by Type
9.3.5.1.2 Australia Non Narcotic Analgesics Market by Application
9.3.5.2 China Non Narcotic Analgesics Market
9.3.5.2.1 China Non Narcotic Analgesics Market by Type
9.3.5.2.2 China Non Narcotic Analgesics Market by Application
9.3.5.3 India Non Narcotic Analgesics Market
9.3.5.3.1 India Non Narcotic Analgesics Market by Type
9.3.5.3.2 India Non Narcotic Analgesics Market by Application
9.3.5.4 Japan Non Narcotic Analgesics Market
9.3.5.4.1 Japan Non Narcotic Analgesics Market by Type
9.3.5.4.2 Japan Non Narcotic Analgesics Market by Application
9.3.5.5 South Korea Non Narcotic Analgesics Market
9.3.5.5.1 South Korea Non Narcotic Analgesics Market by Type
9.3.5.5.2 South Korea Non Narcotic Analgesics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Non Narcotic Analgesics Market Overview
9.4.2 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis
9.4.3 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Non Narcotic Analgesics Market
9.4.5.1.1 South Africa Non Narcotic Analgesics Market by Type
9.4.5.1.2 South Africa Non Narcotic Analgesics Market by Application
9.4.5.2 Saudi Arabia Non Narcotic Analgesics Market
9.4.5.2.1 Saudi Arabia Non Narcotic Analgesics Market by Type
9.4.5.2.2 Saudi Arabia Non Narcotic Analgesics Market by Application
9.4.5.3 U.A.E Non Narcotic Analgesics Market
9.4.5.3.1 U.A.E Non Narcotic Analgesics Market by Type
9.4.5.3.2 U.A.E Non Narcotic Analgesics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Non Narcotic Analgesics Market Overview
9.5.2 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis
9.5.3 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Non Narcotic Analgesics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Non Narcotic Analgesics Market
9.5.5.1.1 Brazil Non Narcotic Analgesics Market by Type
9.5.5.1.2 Brazil Non Narcotic Analgesics Market by Application
9.5.5.2 Argentina Non Narcotic Analgesics Market
9.5.5.2.1 Argentina Non Narcotic Analgesics Market by Type
9.5.5.2.2 Argentina Non Narcotic Analgesics Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NON NARCOTIC ANALGESICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NON NARCOTIC ANALGESICS MARKET, KEY COMPANY PROFILES
12.1. AKRON, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIODELIVERY SCIENCES INTERNATIONAL, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ENDO PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAXOSMITHKLINE PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. RECKITT BENCKISER
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI S.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Akron, Inc.
2. Allergan plc
3. BioDelivery Sciences International, Inc.
4. Endo Pharmaceuticals
5. GlaxoSmithKline PLC
6. Novartis AG
7. Pfizer
8. Reckitt Benckiser
9. Sanofi S.A.
10. Teva Pharmaceuticals
1. Akron, Inc.
2. Allergan plc
3. BioDelivery Sciences International, Inc.
4. Endo Pharmaceuticals
5. GlaxoSmithKline PLC
6. Novartis AG
7. Pfizer
8. Reckitt Benckiser
9. Sanofi S.A.
10. Teva Pharmaceuticals